Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Measles-related hospitalizations and associated complications in jerusalem, 2018-2019.

Ben-Chetrit E, Oster Y, Jarjou'i A, Megged O, Lachish T, Cohen MJ, Stein-Zamir C, Ivgi H, Rivkin M, Milgrom Y, Averbuch D, Korem M, Wolf DG, Wiener-Well Y.

Clin Microbiol Infect. 2019 Sep 6. pii: S1198-743X(19)30485-9. doi: 10.1016/j.cmi.2019.08.022. [Epub ahead of print]

PMID:
31499179
2.

Saliva real time polymerase chain reaction for targeted screening of congenital cytomegalovirus infection.

Eventov-Friedman S, Manor H, Bar-Oz B, Averbuch D, Caplan O, Lifshitz A, Bdolah-Abram T, Wolf DG.

J Infect Dis. 2019 Jul 15. pii: jiz373. doi: 10.1093/infdis/jiz373. [Epub ahead of print]

PMID:
31310307
3.

Digital PCR in bone marrow trephine biopsies is highly sensitive for MYD88L265P detection in lymphomas with plasmacytic/plasmacytoid differentiation.

Willenbacher E, Willenbacher W, Wolf DG, Zelger B, Peschel I, Manzl C, Haun M, Brunner A.

Br J Haematol. 2019 Jul;186(1):189-191. doi: 10.1111/bjh.15792. Epub 2019 Feb 14. No abstract available.

PMID:
30763982
4.

Intensive Care Admissions and Associated Severity of Influenza B Versus A During Influenza B Vaccine-mismatched Seasons.

Korem M, Orenbuch-Harroch E, Ben-Chetrit E, Israel S, Cohen MJ, Sviri S, Levin PD, Mandelboim M, Wolf DG.

Clin Infect Dis. 2019 Aug 30;69(6):1049-1052. doi: 10.1093/cid/ciz053.

PMID:
30715225
5.

HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia.

Wolday D, Derese M, Gebressellassie S, Tsegaye B, Ergete W, Gebrehiwot Y, Caplan O, Wolf DG, Maayan S.

Infect Agent Cancer. 2018 Aug 14;13:28. doi: 10.1186/s13027-018-0201-x. eCollection 2018.

6.

Evaluation of Nursing Facility Resident Safety During Implementation of the INTERACT Quality Improvement Program.

Tappen RM, Newman D, Huckfeldt P, Yang Z, Engstrom G, Wolf DG, Shutes J, Rojido C, Ouslander JG.

J Am Med Dir Assoc. 2018 Oct;19(10):907-913.e1. doi: 10.1016/j.jamda.2018.06.017. Epub 2018 Aug 11.

PMID:
30108035
7.

The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.

Dassa L, Seidel E, Oiknine-Djian E, Yamin R, Wolf DG, Le-Trilling VTK, Mandelboim O.

J Virol. 2018 Aug 16;92(17). pii: e00162-18. doi: 10.1128/JVI.00162-18. Print 2018 Sep 1.

8.

The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.

Oiknine-Djian E, Weisblum Y, Panet A, Wong HN, Haynes RK, Wolf DG.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00288-18. doi: 10.1128/AAC.00288-18. Print 2018 Jul.

9.

Diagnosis of HIV-1 infection: Performance of Xpert Qual and Geenius supplemental assays in fourth generation ELISA-reactive samples.

Rakovsky A, Gozlan Y, Bassal R, Wax M, Shirazi R, Bakhanashvili M, Kra-Oz Z, Radian-Sade S, Ben-Zvi H, Schreiber L, Wolf DG, Shemer-Avni Y, Chemtob D, Mendelson E, Mor O.

J Clin Virol. 2018 Apr;101:7-10. doi: 10.1016/j.jcv.2018.01.007. Epub 2018 Jan 17.

PMID:
29414189
10.

APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.

Weisblum Y, Oiknine-Djian E, Zakay-Rones Z, Vorontsov O, Haimov-Kochman R, Nevo Y, Stockheim D, Yagel S, Panet A, Wolf DG.

J Virol. 2017 Nov 14;91(23). pii: e01296-17. doi: 10.1128/JVI.01296-17. Print 2017 Dec 1.

11.

Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.

Glasner A, Oiknine-Djian E, Weisblum Y, Diab M, Panet A, Wolf DG, Mandelboim O.

J Virol. 2017 Oct 27;91(22). pii: e00785-17. doi: 10.1128/JVI.00785-17. Print 2017 Nov 15.

12.

Diagnosis of Cytomegalovirus Infection during Exacerbation of Ulcerative Colitis.

Levin A, Yaari S, Stoff R, Caplan O, Wolf DG, Israeli E.

Digestion. 2017;96(3):142-148. doi: 10.1159/000479865. Epub 2017 Aug 26.

PMID:
28848127
13.

Barriers and Facilitators to Implementing a Change Initiative in Long-Term Care Using the INTERACT® Quality Improvement Program.

Tappen RM, Wolf DG, Rahemi Z, Engstrom G, Rojido C, Shutes JM, Ouslander JG.

Health Care Manag (Frederick). 2017 Jul/Sep;36(3):219-230. doi: 10.1097/HCM.0000000000000168.

14.

Efficacy of inactivation of viral contaminants in hyperimmune horse plasma against botulinum toxin by low pH alone and combined with pepsin digestion.

Torgeman A, Mador N, Dorozko M, Lifshitz A, Eschar N, White MD, Wolf DG, Epstein E.

Biologicals. 2017 Jul;48:24-27. doi: 10.1016/j.biologicals.2017.06.003. Epub 2017 Jun 17.

PMID:
28633975
15.

The expression level of C19MC miRNAs in early pregnancy and in response to viral infection.

Dumont TMF, Mouillet JF, Bayer A, Gardner CL, Klimstra WB, Wolf DG, Yagel S, Balmir F, Binstock A, Sanfilippo JS, Coyne CB, Larkin JC, Sadovsky Y.

Placenta. 2017 May;53:23-29. doi: 10.1016/j.placenta.2017.03.011. Epub 2017 Mar 16.

16.

Letters.

Shamriz O, Wolf DG, Bennett-Back O, Brooks R, Kleid DM, Hashavya S.

Isr Med Assoc J. 2016 Aug;18(8):506. No abstract available.

17.

Analysis of Influenza and RSV dynamics in the community using a 'Local Transmission Zone' approach.

Almogy G, Stone L, Bernevig BA, Wolf DG, Dorozko M, Moses AE, Nir-Paz R.

Sci Rep. 2017 Feb 9;7:42012. doi: 10.1038/srep42012.

18.

Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface.

Weisblum Y, Oiknine-Djian E, Vorontsov OM, Haimov-Kochman R, Zakay-Rones Z, Meir K, Shveiky D, Elgavish S, Nevo Y, Roseman M, Bronstein M, Stockheim D, From I, Eisenberg I, Lewkowicz AA, Yagel S, Panet A, Wolf DG.

J Virol. 2017 Jan 31;91(4). pii: e01905-16. doi: 10.1128/JVI.01905-16. Print 2017 Feb 15.

19.

HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion.

Enk J, Levi A, Weisblum Y, Yamin R, Charpak-Amikam Y, Wolf DG, Mandelboim O.

Cell Rep. 2016 Oct 18;17(4):949-956. doi: 10.1016/j.celrep.2016.09.077.

20.

Hospital Transfers of Skilled Nursing Facility (SNF) Patients Within 48 Hours and 30 Days After SNF Admission.

Ouslander JG, Naharci I, Engstrom G, Shutes J, Wolf DG, Rojido M, Tappen R, Newman D.

J Am Med Dir Assoc. 2016 Sep 1;17(9):839-45. doi: 10.1016/j.jamda.2016.05.021. Epub 2016 Jun 24.

21.

CEACAM1-Mediated Inhibition of Virus Production.

Vitenshtein A, Weisblum Y, Hauka S, Halenius A, Oiknine-Djian E, Tsukerman P, Bauman Y, Bar-On Y, Stern-Ginossar N, Enk J, Ortenberg R, Tai J, Markel G, Blumberg RS, Hengel H, Jonjic S, Wolf DG, Adler H, Kammerer R, Mandelboim O.

Cell Rep. 2016 Jun 14;15(11):2331-9. doi: 10.1016/j.celrep.2016.05.036. Epub 2016 Jun 2.

22.

HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2.

Yamin R, Lecker LSM, Weisblum Y, Vitenshtein A, Le-Trilling VTK, Wolf DG, Mandelboim O.

Cell Rep. 2016 May 17;15(7):1542-1553. doi: 10.1016/j.celrep.2016.04.042. Epub 2016 May 5.

23.

Lessons Learned From Root Cause Analyses of Transfers of Skilled Nursing Facility (SNF) Patients to Acute Hospitals: Transfers Rated as Preventable Versus Nonpreventable by SNF Staff.

Ouslander JG, Naharci I, Engstrom G, Shutes J, Wolf DG, Alpert G, Rojido C, Tappen R, Newman D.

J Am Med Dir Assoc. 2016 Jul 1;17(7):596-601. doi: 10.1016/j.jamda.2016.02.014. Epub 2016 Mar 24.

PMID:
27052562
24.

Root Cause Analyses of Transfers of Skilled Nursing Facility Patients to Acute Hospitals: Lessons Learned for Reducing Unnecessary Hospitalizations.

Ouslander JG, Naharci I, Engstrom G, Shutes J, Wolf DG, Alpert G, Rojido C, Tappen R, Newman D.

J Am Med Dir Assoc. 2016 Mar 1;17(3):256-62. doi: 10.1016/j.jamda.2015.11.018. Epub 2016 Jan 14.

PMID:
26777066
25.

Coxsackievirus A6 Polymorphic Exanthem in Israeli Children.

Renert-Yuval Y, Marva E, Weil M, Shulman LM, Gencylmaz N, Sheffer S, Wolf DG, Molho-Pessach V.

Acta Derm Venereol. 2016 May;96(4):546-9. doi: 10.2340/00015555-2261.

26.

Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface.

Weisblum Y, Panet A, Zakay-Rones Z, Vitenshtein A, Haimov-Kochman R, Goldman-Wohl D, Oiknine-Djian E, Yamin R, Meir K, Amsalem H, Imbar T, Mandelboim O, Yagel S, Wolf DG.

Virology. 2015 Nov;485:289-96. doi: 10.1016/j.virol.2015.06.023. Epub 2015 Aug 28.

27.

Transition toward Human Cytomegalovirus Susceptibility in Early Human Embryonic Stem Cell-Derived Neural Precursors.

Berger AA, Gil Y, Panet A, Weisblum Y, Oiknine-Djian E, Gropp M, Steiner D, Reubinoff BE, Wolf DG.

J Virol. 2015 Nov;89(21):11159-64. doi: 10.1128/JVI.01742-15. Epub 2015 Aug 19.

28.

A heart breaking case of rapidly developing severe hemophagocytic syndrome secondary to chronic active EBV infection; a case report and review of the literature.

Tawfik K, Liron Y, Ayman AR, Schneider R, Wolf DG, Ronen L.

J Clin Virol. 2015 Jun;67:14-6. doi: 10.1016/j.jcv.2015.03.017. Epub 2015 Mar 24. Review.

PMID:
25959150
29.

Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK Cells.

Seidel E, Le VTK, Bar-On Y, Tsukerman P, Enk J, Yamin R, Stein N, Schmiedel D, Oiknine Djian E, Weisblum Y, Tirosh B, Stastny P, Wolf DG, Hengel H, Mandelboim O.

Cell Rep. 2015 Feb 17;10(6):968-982. doi: 10.1016/j.celrep.2015.01.029. Epub 2015 Feb 12.

30.

Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.

Weisblum Y, Panet A, Haimov-Kochman R, Wolf DG.

Semin Immunopathol. 2014 Nov;36(6):615-25. doi: 10.1007/s00281-014-0449-1. Epub 2014 Oct 8. Review.

PMID:
25291972
31.

MicroRNA editing facilitates immune elimination of HCMV infected cells.

Nachmani D, Zimmermann A, Oiknine Djian E, Weisblum Y, Livneh Y, Khanh Le VT, Galun E, Horejsi V, Isakov O, Shomron N, Wolf DG, Hengel H, Mandelboim O.

PLoS Pathog. 2014 Feb 27;10(2):e1003963. doi: 10.1371/journal.ppat.1003963. eCollection 2014 Feb.

32.

Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders.

Shamriz O, Vilk SR, Wolf DG, Ta-Shma A, Averbuch D, Weintraub M, Stepensky P.

Clin Immunol. 2014 Apr;151(2):79-83. doi: 10.1016/j.clim.2014.01.007. Epub 2014 Feb 4.

PMID:
24584040
33.

Coxsackievirus A6-related hand foot and mouth disease: skin manifestations in a cluster of adult patients.

Ben-Chetrit E, Wiener-Well Y, Shulman LM, Cohen MJ, Elinav H, Sofer D, Feldman I, Marva E, Wolf DG.

J Clin Virol. 2014 Mar;59(3):201-3. doi: 10.1016/j.jcv.2013.12.012. Epub 2014 Jan 7.

PMID:
24457116
34.

High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation.

Shmueli E, Or R, Shapira MY, Resnick IB, Caplan O, Bdolah-Abram T, Wolf DG.

J Infect Dis. 2014 Feb 15;209(4):557-61. doi: 10.1093/infdis/jit475. Epub 2013 Aug 27.

PMID:
23983215
35.

Advances in immunotherapy of chronic myeloid leukemia CML.

Held SA, Heine A, Mayer KT, Kapelle M, Wolf DG, Brossart P.

Curr Cancer Drug Targets. 2013 Sep;13(7):768-74. Review.

PMID:
23906051
36.

HSV-2 specifically down regulates HLA-C expression to render HSV-2-infected DCs susceptible to NK cell killing.

Elboim M, Grodzovski I, Djian E, Wolf DG, Mandelboim O.

PLoS Pathog. 2013 Mar;9(3):e1003226. doi: 10.1371/journal.ppat.1003226. Epub 2013 Mar 28.

37.

Antiphospholipid antibodies during infectious mononucleosis and their long term clinical significance.

Ben-Chetrit E, Wiener-Well Y, Fadeela A, Wolf DG.

J Clin Virol. 2013 Apr;56(4):312-5. doi: 10.1016/j.jcv.2012.12.011. Epub 2013 Jan 3.

PMID:
23290387
38.

Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.

Weisblum Y, Panet A, Zakay-Rones Z, Haimov-Kochman R, Goldman-Wohl D, Ariel I, Falk H, Natanson-Yaron S, Goldberg MD, Gilad R, Lurain NS, Greenfield C, Yagel S, Wolf DG.

J Virol. 2011 Dec;85(24):13204-13. doi: 10.1128/JVI.05749-11. Epub 2011 Oct 5.

39.

Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal influenza among children, Israel.

Engelhard D, Bromberg M, Averbuch D, Tenenbaum A, Goldmann D, Kunin M, Shmueli E, Yatsiv I, Weintraub M, Mandelboim M, Strauss-Liviatan N, Anis E, Mendelson E, Shohat T, Wolf DG, Shapiro M, Grotto I.

Emerg Infect Dis. 2011 Sep;17(9):1740-3. doi: 10.3201/eid1709.102022.

40.

An outbreak of adenovirus type 7 in a residential facility for severely disabled children.

Ghanaiem H, Averbuch D, Koplewitz BZ, Yatsiv I, Braun J, Dehtyar N, Wolf DG, Mandelboim M, Engelhard D.

Pediatr Infect Dis J. 2011 Nov;30(11):948-52. doi: 10.1097/INF.0b013e31822702fe.

PMID:
21694661
41.

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.

Wolf DG, Shimoni A, Resnick IB, Stamminger T, Neumann AU, Chou S, Efferth T, Caplan O, Rose J, Nagler A, Marschall M.

Antiviral Res. 2011 Jun;90(3):183-6. doi: 10.1016/j.antiviral.2011.03.184. Epub 2011 Apr 3.

42.

Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment.

Goldberg MD, Honigman A, Weinstein J, Chou S, Taraboulos A, Rouvinski A, Shinder V, Wolf DG.

J Virol. 2011 Apr;85(7):3375-84. doi: 10.1128/JVI.01952-10. Epub 2011 Jan 19.

43.

The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.

Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, Dray L, Djian E, Strauss-Liviatan N, Grotto I, Wolf DG, Or R.

Vaccine. 2011 Feb 17;29(9):1777-82. doi: 10.1016/j.vaccine.2010.12.113. Epub 2011 Jan 7.

PMID:
21216315
44.

Influenza A infection in young infants.

Rekhtman D, Wolf DG, Levy-Khademi F, Averbuch D, Kerem E, Wexler ID.

Arch Dis Child. 2011 Nov;96(11):1085-7. doi: 10.1136/adc.2010.182873. Epub 2010 Oct 27.

PMID:
21030378
45.

The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination.

Nachmani D, Lankry D, Wolf DG, Mandelboim O.

Nat Immunol. 2010 Sep;11(9):806-13. doi: 10.1038/ni.1916. Epub 2010 Aug 8.

PMID:
20694010
46.

Cytomegalovirus infection in pediatric rheumatic diseases: a review.

Eisenstein EM, Wolf DG.

Pediatr Rheumatol Online J. 2010 May 20;8:17. doi: 10.1186/1546-0096-8-17.

47.

Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.

Amir J, Wolf DG, Levy I.

Eur J Pediatr. 2010 Sep;169(9):1061-7. doi: 10.1007/s00431-010-1176-9. Epub 2010 Mar 16.

PMID:
20232081
48.

Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children.

Wolf DG, Greenberg D, Shemer-Avni Y, Givon-Lavi N, Bar-Ziv J, Dagan R.

J Pediatr. 2010 Jan;156(1):115-20. doi: 10.1016/j.jpeds.2009.07.014.

PMID:
19782998
49.

Analysis of human cytomegalovirus-encoded microRNA activity during infection.

Stern-Ginossar N, Saleh N, Goldberg MD, Prichard M, Wolf DG, Mandelboim O.

J Virol. 2009 Oct;83(20):10684-93. doi: 10.1128/JVI.01292-09. Epub 2009 Aug 5.

50.

Epstein-barr virus-related diarrhea or exacerbation of inflammatory bowel disease: diagnostic dilemma.

Weinberg I, Neuman T, Margalit M, Ayman F, Wolf DG, Ben-Yehuda A.

J Clin Microbiol. 2009 May;47(5):1588-90. doi: 10.1128/JCM.02477-08. Epub 2009 Mar 11.

Supplemental Content

Support Center